Profile data is unavailable for this security.
About the company
Jinan High-tech Development Co Ltd is a China-based company principally engaged in the in vitro diagnostics business. The Company operates three segments. The Real Estate and Property Services Business segment is mainly engaged in real estate development and sales and the provision of property and property leasing services. The In Vitro Diagnostics Business segment is mainly engaged in the research and development, production and sales of molecular diagnostic reagents and equipment. The products are mainly used in the fields of infectious disease prevention and control, pathogenic microorganism detection, food safety testing and other fields. The Other Business segment is mainly engaged in trading business and other businesses. The Company mainly conducts its businesses in the domestic market.
- Revenue in CNY (TTM)555.10m
- Net income in CNY-119.73m
- Incorporated1992
- Employees716.00
- LocationJinan High-tech Development Co Ltd3F,Sectn A,Jn Intl Cnvntn&Exbtn CtrNo. 1, Xinyu South RoadHigh-Tech Development ZoneJI'NAN 250101ChinaCHN
- Phone+86 53 186171188
- Fax+86 53 186171188
- Websitehttp://www.jhhg.net.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novoprotein Scientific Inc | 136.28m | -927.60k | 2.52bn | 579.00 | -- | 1.15 | -- | 18.50 | -0.0132 | -0.0132 | 1.94 | 31.19 | 0.0585 | 0.4493 | 1.67 | 235,364.30 | -0.0398 | -- | -0.0409 | -- | 70.17 | -- | -0.6807 | -- | 34.49 | -- | 0.0353 | -- | -42.09 | -- | -85.84 | -- | -- | -- |
Ginwa Enterprise Group Inc | 572.93m | -23.61m | 2.52bn | 553.00 | -- | 1.56 | -- | 4.40 | -0.0633 | -0.0633 | 1.53 | 4.32 | 0.2988 | 4.74 | 5.64 | 1,036,046.00 | -1.23 | 0.3641 | -1.44 | 0.4141 | 75.60 | 73.64 | -4.12 | 1.15 | 3.33 | 0.3439 | 0.0206 | 124.25 | -2.41 | -5.37 | -228.19 | -- | 61.66 | -- |
Beijing Succeeder Technology Inc | 284.54m | 120.76m | 2.55bn | 296.00 | 21.09 | 1.56 | -- | 8.95 | 1.14 | 1.14 | 2.68 | 15.36 | 0.1711 | 2.39 | 9.52 | 961,290.60 | 7.26 | 7.77 | 7.63 | 8.25 | 62.48 | 61.03 | 42.43 | 38.34 | 14.58 | -- | 0.00007 | 22.22 | 20.40 | 6.60 | 12.29 | 15.57 | 99.03 | -- |
Shanghai Fudan Forward S&T Co Ltd | 665.16m | -6.01m | 2.58bn | 1.36k | -- | 3.24 | -- | 3.88 | -0.0089 | -0.0089 | 0.9791 | 1.16 | 0.3776 | 0.6066 | 8.47 | 488,010.90 | -0.3031 | -0.8781 | -0.5073 | -1.53 | 40.85 | 43.22 | -0.8027 | -1.85 | 0.4956 | -1.83 | 0.3817 | -- | -13.86 | -7.58 | 196.17 | -32.57 | -13.88 | -- |
Cabio Biotech Wuhan Co Ltd | 473.06m | 101.38m | 2.62bn | 508.00 | 26.23 | 1.75 | -- | 5.54 | 0.594 | 0.594 | 2.77 | 8.92 | 0.2948 | 2.49 | 2.27 | 931,222.90 | 6.01 | 7.81 | 6.55 | 8.34 | 41.34 | 46.96 | 20.40 | 28.65 | 6.19 | -- | 0.008 | 39.86 | 2.39 | 9.18 | 41.95 | -1.19 | 89.01 | -- |
Jinan High-tech Development Co Ltd | 555.10m | -119.73m | 2.64bn | 716.00 | -- | 13.54 | -- | 4.75 | -0.1353 | -0.1353 | 0.6275 | 0.2201 | 0.1874 | 0.6198 | 0.6935 | 775,274.40 | -4.46 | -2.99 | -22.92 | -9.42 | 15.19 | 30.52 | -23.79 | -10.84 | 0.5687 | -- | 0.4146 | -- | -58.29 | -13.80 | -618.17 | -- | -35.45 | -- |
Ningbo Menovo Pharmaceutical Co Ltd | 1.23bn | -17.82m | 2.67bn | 2.35k | -- | 1.25 | -- | 2.17 | -0.0997 | -0.0997 | 5.23 | 9.99 | 0.2811 | 1.31 | 6.18 | 523,989.50 | -0.3253 | 4.94 | -0.4782 | 7.83 | 30.72 | 35.39 | -1.16 | 13.71 | 0.7935 | 0.7647 | 0.4042 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
Henan Taloph Pharmaceutical Stock Co Ltd | 2.01bn | 61.13m | 2.73bn | 2.35k | 46.50 | 1.68 | -- | 1.36 | 0.1024 | 0.1024 | 3.51 | 2.84 | 0.556 | 3.30 | 2.13 | 853,677.20 | 1.72 | 0.272 | 3.55 | 0.4981 | 26.76 | 27.97 | 3.09 | 0.5501 | 0.9283 | 2.02 | 0.3637 | 28.70 | 5.57 | 11.62 | 160.32 | -- | -8.27 | -- |
Holder | Shares | % Held |
---|---|---|
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 63.50k | 0.01% |
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 2.40k | 0.00% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 0.00 | 0.00% |
Sealand Securities Co., Ltd. (Investment Management)as of 31 Dec 2023 | 0.00 | 0.00% |
Truvalue Asset Management Co. Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |